Group 1 - The biotech forum has seen significant discussions around buy-write or covered call opportunities on selected biotech stocks over recent months [1] - Solventum Corporation (NYSE: SOLV) has been highlighted as a medical solution and device provider, with its stock price declining approximately 20% since the initial article [2]